Viridian Therapeutics, Inc. earnings per share and revenue

VRDN earnings per share for the last quarter are -1.15 USD whereas the estimation was -1.06 USD which accounts for -8.77% surprise. Company revenue for the same period amounts to 86.00 k USD despite the estimated figure of 84.92 k USD. Estimated earnings per share for the next quarter are -1.04 USD, and revenue is expected to reach 44.00 k USD. Also watch annual changes over time to get a bigger picture of VRDN earnings per share and revenue dynamics.